New UCL-led, SPCR study published in The Lancet Psychiatry warns that many people with dementia are prescribed antipsychotic drugs for longer than national guidelines recommend: www.spcr.nihr.ac.uk/news/uk-deme... #SPCR #PrimaryCare #Research #Dementia @ucl-primarycare.bsky.social @thelancet.com

New podcast out now 🎙️ Delighted to share a short Lancet Psychiatry – In Conversation With episode about our recent paper on antipsychotic prescribing in people living with dementia 🎧 Listen here: www.thelancet.com/multimedia/p... @ucl-primarycare.bsky.social @qmulpsychiatry.bsky.social @ucl.ac.uk

New Lancet Psychiatry paper on antipsychotic prescribing in dementia. These drugs carry serious risks, so exposure should be minimal. In England we found: ~1/10 treated; 1/5 start above min dose (~1/3 stay high); 50% exposed >7 months; ~50% restart. Read/share: www.thelancet.com/journals/lan...

Our paper is #1 in the Top 10 BJGP 2024 list!

BJGP Top 10 Research 2024 No. 1 #BJGPtop10 – Parkinson's disease & anxiety: Risk of developing Parkinson’s increased with a history of anxiety and may represent a prodromal phase for Parkinson’s doi.org/10.3399/BJGP... @uclqsion.bsky.social @ucl-primarycare.bsky.social @ucliehc.bsky.social

BJGP Top 10 Research 2024 No. 1 #BJGPtop10 – Parkinson's disease & anxiety: Risk of developing Parkinson’s increased with a history of anxiety and may represent a prodromal phase for Parkinson’s doi.org/10.3399/BJGP... @nihrspcr.bsky.social @ashmore1973.bsky.social

BJGP Top 10 Research 2024 The #BJGPTop10 resumes on Monday 3 February 2025 See you next week!

Dr. Juan Carlos Bazo Alvarez, a former NIHR Three Research Schools' Mental Health Programme Fellow, has recently celebrated the publication of two research papers stemming from his Fellowship: bit.ly/42pCF1z @georginaspcr.bsky.social @ashmore1973.bsky.social